Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 100 filers reported holding Y-MABS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,372 | -31.0% | 3,371 | -14.0% | 0.00% | – |
Q2 2023 | $26,624 | +20.0% | 3,921 | -11.5% | 0.00% | – |
Q1 2023 | $22,194 | -70.6% | 4,430 | -71.4% | 0.00% | – |
Q4 2022 | $75,517 | -66.1% | 15,475 | 0.0% | 0.00% | – |
Q3 2022 | $223,000 | -31.4% | 15,475 | -27.9% | 0.00% | – |
Q2 2022 | $325,000 | +173.1% | 21,468 | +114.7% | 0.00% | – |
Q1 2022 | $119,000 | -26.5% | 9,999 | 0.0% | 0.00% | – |
Q4 2021 | $162,000 | -42.6% | 9,999 | +0.9% | 0.00% | – |
Q3 2021 | $282,000 | +73.0% | 9,914 | +105.2% | 0.00% | – |
Q2 2021 | $163,000 | +19.0% | 4,831 | +6.7% | 0.00% | – |
Q1 2021 | $137,000 | -35.4% | 4,528 | +5.3% | 0.00% | – |
Q4 2020 | $212,000 | +27.7% | 4,301 | -0.9% | 0.00% | – |
Q3 2020 | $166,000 | -32.0% | 4,342 | -23.3% | 0.00% | – |
Q2 2020 | $244,000 | +106.8% | 5,659 | +25.1% | 0.00% | – |
Q1 2020 | $118,000 | -32.6% | 4,522 | -19.2% | 0.00% | – |
Q4 2019 | $175,000 | +98.9% | 5,599 | +65.1% | 0.00% | – |
Q3 2019 | $88,000 | +12.8% | 3,392 | 0.0% | 0.00% | – |
Q2 2019 | $78,000 | +178.6% | 3,392 | +215.8% | 0.00% | – |
Q1 2019 | $28,000 | +27.3% | 1,074 | 0.0% | 0.00% | – |
Q4 2018 | $22,000 | – | 1,074 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 191,176 | $2,271,000 | 2.63% |
Sofinnova Investments, Inc. | 2,194,278 | $26,068,000 | 1.98% |
MPM BioImpact LLC | 443,702 | $5,271,000 | 1.42% |
Soleus Capital Management, L.P. | 238,982 | $2,839,000 | 0.37% |
Lombard Odier Asset Management (Switzerland) SA | 221,774 | $2,635,000 | 0.21% |
Artal Group S.A. | 400,000 | $4,752,000 | 0.20% |
Polar Capital Holdings Plc | 2,877,671 | $34,187,000 | 0.15% |
ASHFORD CAPITAL MANAGEMENT INC | 106,770 | $1,268,000 | 0.14% |
Cormorant Asset Management, LP | 150,000 | $1,782,000 | 0.14% |
Virtus ETF Advisers LLC | 23,646 | $281,000 | 0.13% |